內容教程成果31maj written resolutions of all shareholders

SHAREPURCHASETHISSHAREPURCHASEAGREEMENT(this"Agreement")ismadeandenteredintoasof10October,2014(the"SigningDate")byandamong:GreenDragonAdvisory,acompanylimitedbysharesincorporatedandexistingunderthelawsofBritishVirginIslands(the"Company"),thepartieslistedonPartIofExhibitAattachedhereto(the"Founders"andeacha"Founder");thepartieslistedonPartIIofExhibitAattachedhereto(the“MajorthepartieslistedonPartIIIofExhibitAattachedhereto(“ContractingGroupCompanies”andeacha“ContractingGroupCompany”);andthepartieslistedonPartIVofExhibitAattachedhereto(the"Investors",andeachanEachoftheforgoingpartiesisreferredtohereinindividuallyasa"Party"andcollectivelyasthe"Parties".TheCompanyisaBritishVirginIslandscompanylimitedbysharesestablishedasaholdingcompanyonDecember16,2013withitsprincipalplaceofbusinessinthePeople’s(the“PRC”,which,forpurposeofthisAgreement,doesnotincludetheorMacauSARs,orregion).TheGroupCompaniesareprimarilyengagedintheestablishmentandexpansionofbusinessinlaser-lightfacialcleaningservicesandotherrelatedaestheticproductsandservices(the“PrincipalBusiness”),abusinesswhichoriginatedwithAMPPL(definedinExhibitB).TheInvestorsdesiretoinvestintheCompanybysubscribingforandpurchasingcertainpreferredshares,andtheCompanydesirestoissueandsellsuchpreferredsharestotheInvestors,pursuanttothetermsandsubjecttotheconditionsofthisAgreement.ThePartiesdesiretoenterintothisAgreementandmaketherespectiverepresentations,warranties,covenantsandagreementssetforthhereinonthetermsandconditionssetforthNOW,THEREFORE,inconsiderationoftheforegoingrecitals,themutualpromiseshereinaftersetforth,andothergoodandvaluableconsideration,thereceiptandsufficiencyofwhichareherebyacknowledged,thePartiesherebyagreeasfollows:UnlessotherwisedefinedinthisAgreement,capitalizedtermsusedinthisAgreementshallhavethemeaningssetforthinExhibitB.PurchaseandSaleofSeriesAPreferredShares.SubjecttothetermsandconditionsofthisAgreement,theCompanyagreestoissueandselltotheInvestorsanaggregatenumberof1,192,308SeriesAPreferredShares(the"PurchaseShares")foranaggregatepurchasepriceofUS$5,000,000(the"AggregatePurchasePrice").TheInvestorsagreetosubscribeforandpurchasefromtheCompanyitsportionofthePurchaseSharesforitsportionoftheAggregatePurchasePriceattheClosingassetforthoppositesuchInvestors'nameonPartIVofExhibitA.TheInvestorsshallpayitsapplicableamountoftheAggregatePurchasePriceattheClosingbywiretransferofimmediayavailablefundstothebankaccountdesignatedbytheCompanypriortotheClosing.FFCapital’sPurchaseofNewSeriesAPreferredShares.SubjecttothetermsandconditionsofthisAgreement,theCompanyagreestograntFFCapital("FFCapital")arighttopurchaseattheClosingatotalnumberof851,648SeriesAPreferredShares(the"FFCapital’sPurchaseShares")whichwillaccountfor8.696%oftheCompany'soutstandingshares(calculatedonafully-dilutedbasis)atapurchasepriceofUS$4,000,000(the"FFCapital’sPurchasePrice").FFCapitalshallpayFFCapital’sPurchaseSharesbywiretransferofimmediayavailablefundstothebankaccountdesignatedbytheCompany.Closing.TheconsummationoftheissueandpurchaseofthePurchaseSharesshalltakeplaceremoyviatheexchangeof sandsignaturesonthedateoftheClosing(the"ClosingDate"),whichshallbenolaterthanfifteen(15)BusinessDaysafterallClosingConditionshavebeensatisfiedorwaived(orsuchothertimeandplaceastheCompanyandtheInvestorsshallmutuallyagree)(the“Closing”).ClosingDeliverables.AttheClosing,theCompanyshalldeliver(orcausetobedelivered)totheInvestorsacertifiedtruecopyoftheCompany'supdatedregisterofmembers,reflectingsuchInvestors’ownershipofthePurchaseShares,and,totheextentnotpreviouslydelivered,such s,instrumentsanditemsrequiredtobedeliveredinconnectionwiththesatisfactionoftheClosingConditionsinrespectofsuchClosing.Withinseven(7)BusinessDaysaftertheClosingDate,theCompanyshalldelivertotheInvestorsoriginalsharesissuedtosuchInvestorsrepresentingthePurchaseSharespurchasedbysuchInvestorsatsuchClosing.ClosingPayment.AttheClosingandagainstthedeliveryoftheitemspursuanttoSection3.2(i)above,theInvestorsshallpayitsportionoftheAggregatePurchasePricepayableincashattheClosingtotheCompanybywiretransferofimmediayavailablefundstoabankaccountdesignatedbytheCompany.TheCompanyshallprovideitsbankaccountinformationtotheInvestorsatleastthree(3)BusinessDayspriortotheClosingDate.REPRESENTATIONSANDRepresentationsandWarrantiesofCovenantors.SubjecttosuchexceptionsasmaybespecificallysetforthintheDisclosureScheduleattachedheretoasExhibitE(the“DisclosureSchedule”),eachoftheFounders,theMajorShareholder,andeachoftheContractingGroupCompanies(collectively,the“Covenantors”andeacha“Covenantor”)hereby,jointlyandseverally,representsandwarrantstotheInvestorsthateachofthestatementscontainedinExhibitDattachedhereto(the“CovenantorRepresentationsandWarranties”)istrue,correctandcompleteasoftheSigningDateandwillbetrue,correctandcompleteasoftheClosingDate.RepresentationsandWarrantiesoftheInvestors.EachoftheInvestorsherebyseverallyrepresentsandwarrantstotheCovenantorsthattherepresentationsandwarrantiessetforthinthisSection4.2(the“InvestorsRepresentationsandWarranties”)aretrueandcorreoftheSigningDateandwillbetrueandcorreoftheClosingDate:DueOrganization.SuchInvestorisdulyincorporated,organized,validlyexistingandingoodstanding(orequivalentstatusintherelevantjurisdiction)underthelawsofthejurisdictionofitsincorporationororganization.Authorization.SuchInvestorhasallrequisitepower,authorityandcapacitytoenterintotheTransaction stowhichitisaparty,andtoperformitsobligationshereunderandthereunder.EachTransactiontowhichitisapartyhasbeendulyauthorized,executedanddeliveredbysuchInvestor.EachTransaction towhichsuchInvestorisaparty,whenexecutedanddeliveredbysuchInvestor,willconstitutevalidandlegallybindingobligationsofit,enforceableagainstitinaccordancewithitsterms.ConditionstoClosing.TheobligationoftheInvestorstopurchasethePurchaseSharesandpaytheclosingpaymentontheClosingDateissubjecttothesatisfaction,orwaiverbytheInvestors,ofeachofthefollowingconditions(the“ClosingConditions”):RepresentationsandWarranties.TheCovenantorRepresentationsandWarrantiesshallbetrueandcorrectandcompleteasoftheSigningDateandasoftheClosingDate,withthesameforceandeffeiftheyweremadeonandasofsuchdate.PerformanceofObligations.EachCovenantorshallhaveperformedandcompliedwithallagreements,obligationsandconditionsthatarerequiredbythe stobeperformedorcompliedwithbyitonorbeforetheProceedingsand s.AllcorporateandotherproceedingsinconnectionwiththetransactionscontemplatedunderthisAgreementandtheother sandallsandinstrumentsincidenttosuchtransactionsshallbecompletedandreasonablysatisfactoryinsubstanceandformtotheApprovals.Allapproval,authorizationorconsentwhicharerequiredtobeobtainedbyeachCovenantorinconnectionwiththeconsummationofthetransactionscontemplatedunderthisAgreementandtheotherTransactionswillhavebeenobtainedpriortoandbeeffectiveasoftheClosing.ClosingMemorandumandArticles.TheamendedandrestatedmemorandumandarticlesofassociationsintheformattachedheretoasPartIofExhibitG(the“MemorandumandArticles”)shallhavebeendulyadoptedbyallnecessaryactionoftheboardofdirectorsandthemembersoftheCompany,andtheMemorandumandArticlesshallhave eeffectivepriortotheClosingwithnoamendmentasoftheClosing.ShareholdersAgreement.TheshareholdersagreementintheformattachedheretoasPartIIofExhibitG(the“ShareholdersAgreement”)shallhavebeendulyexecutedanddeliveredbythepartiesthereto.ityand petitionAgreement.EachoftheKey petitionandassignmentofinventionagreementinformandsubstancereasonablysatisfactorytotheCovenantorResolutions.TheInvestorsshallhavereceivedacertifiedtruecopyofthedirectorsresolutionsandifapplicableshareholders’resolutionsofeachCovenantor(otherthantheFounders)(certifiedbyadirectororthesecretaryofsuchCovenantor)intheagreedform,approvingtheexecution,deliveryandperformanceofeachTransaction towhichsuchCovenantorisaparty.BoardoftheCompany.ThofdirectorsoftheCompanyshallhavebeenconstitutedinaccordancewiththeShareholdersAgreement,andtheInvestorsshallhavereceivedacertifiedtruecopy(certifiedbyadirectororthesecretaryoftheCompany)oftheregisterofdirectorsoftheCompanyevidencingtheappointmentofsuchdirector(s).BoardoftheotherGroupCompanies.IfsoelectedbytheInvestors,thenominee(s)oftheInvestorsshallhavebeenappointedtothofdirectorsoftheGroupCompaniesinaccordancewiththeShareholdersAgreement,andtheInvestorsshallhavereceivedacertifiedtruecopy(certifiedbyadirectororthesecretaryoftheCompany)oftheregisterofdirectorsoftherelevantGroupCompanyevidencingtheappointmentofsuchdirector(s).DueDiligence.TheInvestors’duediligenceinvestigationoftheGroupCompaniesshallhavebeencompletedtotheirreasonablesatisfaction.ApprovalforInvestment.TheInvestorsshallhaveobtainednecessaryinternalapprovalsinconnectionwiththeconsummationofthetransactionscontemplatedunderthisAgreementandtheotherTransactions.NoMaterialAdverseEffect.ThereisnomaterialadverseeffectonanyoftheGroupCompaniesoritsbusiness.ofGoodStanding.TheInvestorsshallhavereceivedaofGoodStandingandofIncumbencyforeachCovenantor(otherthantheFounders)incorporatedotherwisethaninandthePRCwithdateofissuenotearlierthanfive(5)BusinessDayspriortotheClosingDate.ofContinuingRegistration.TheInvestorsshallhavereceivedaofContinuingRegistrationforeachCovenantorincorporatedinHongKongissuedbytheCompaniesRegistryofHongKongwithdateofissuenotearlierthanfive(5)BusinessDayspriortotheClosingDate.CompletionofRestructuring.TheCovenantorsshallcomplete(orcausetobecompleted),tothesatisfactionoftheInvestors,therestructuringstepsinaccordancewiththeRestructuringPlanassetoutinExhibitF(the“RestructuringPlan”),andcomplywiththerequirementsoftheRestructuringPlan.ExecutionofNomineeAgreement.EachofFangJianlinandYuQiangshallenterintoanomineeagreementwiththeCompany,whichshallstipulatethatalltheequityinterestsoftheProcurementCompany,theDirectOperationCompanyandtheFranchiseHoldingCompanythatFangJianlinandYuQiangholdundertheirnamesareonbehalfofandforthebenefitoftheCompanyandsuchnomineeagreementsshallbeinformandsubstancereasonablysatisfactorytotheInvestors.RockStarAdvisorsshallenterintoanomineeagreementwithFangJianlin,whichshallstipulatethat5%equityinterestsoftheCompanythatRockStarAdvisorsholdsunderitsnameareonbehalfofandforthebenefitoftheFangJianlin,andsuchnomineeagreementshallbeinformandsubstancereasonablysatisfactorytotheInvestors.TransferofName.Wei&Lun(Shanghai)InvestmentConsultingCo.,(偉與倫（）投資咨詢)hascompletedthetransferofthenameof“ ”andtheICPLicensetooneoftheDomesticOperationCompaniesdesignatedbytheInvestorsforanominalconsideration.SupplementalAgreementwithAMPPL.TheCompanyshallhaveenteredintoaSupplementalAgreementwithAMPPLforafurtherclarificationandcleardefinitionoftheterm“GrossTurn-over”andaclearcalculationformulaofthelicensingfeestipulatedthereunderinformandsubstancesatisfactorytotheLegalOpinions.TheInvestorsshallhavereceivedlegalopinionsissuedbytheBritishVirginIslandslegalcounsel,legalcounsel,andPRClegalcounseloftheCompanywhichareacceptabletotheInvestorsandaddressedtotheInvestorsinsuchformsandsubstancesatisfactorytotheInvestors.Completion.EachCovenantorshallhavedeliveredtotheInvestorsa,datedtheClosingDate,certifyingthattheconditionsprecedentspecifiedinSection5.1havebeenfulfilled.ernmentAuthority.TherebeingnoernmentAuthoritythatrequestedanyinformationinconnectionwithorinstitutedorthreatenedanyactionorinvestigationtorestrain,prohibitorotherwisechallengetheissueofthePurchaseSharestotheInvestorsortheothertransactionscontemplatedbytheTransactionstowhichanyInvestorisaparty;threatenedtotakeanyactionasaresultoforinanticipationoftheissueofthePurchaseSharestotheInvestorsortheothertransactionscontemplatedbytheTransaction stowhichanyInvestorisaparty;orproposedorenactedanyapplicablelawswhichwouldprohibit,restrictordelaytheissueofthePurchaseSharestotheInvestors,theothertransactionscontemplatedbytheTransaction stowhichanyInvestorisaparty,ortheoperationofanyGroupCompanyaftertheClosing.RestraintorProhibition.Therebeingnoinjunction,restrainingorderorotherorderoranyotherlegalorregulatoryrestraintorprohibitionhavingbeenissuedormadebyanycourtofcompetentjurisdictionorernmentauthorityineffectprecludingorprohibitingconsummationofanypartofthetransactionscontemplatedundertheTransactions.InformationrelatedtoTerenceandNelson.OCBCshallhavereceived,toitssatisfaction,adetailedlistofthefollowinginformationfromeachofTerenceandNelsonfromthedateonwhichtheCompanyisincorporatedtotheClosingrentalalCovenantors’Post-ClosingObligations.UnlessotherwisewaivedbytheInvestors,aftertheClosingtheCovenantorsjointlyandseverallyundertaketoperformorprocuretheperformanceofthefollowingobligations:BoardNomination.FollowingtheClosing,ifsoelectedbytheInvestors,thenominee(s)oftheInvestorsshallhavebeenappointedtothofdirectorsoftheHKCompany,theNewWFOEandtheDomesticOperationCompaniesinaccordancewiththeShareholdersAgreement.TransferofEquityInterestoftheLicensedPPPClinics.FollowingtheClosing,theGroupCompaniesshallcause,totheumextentpermittedbytheapplicablelaws,theequityinterestsofanyandallPPPClinicswhichhaveobtainedallpermits,licensesorother ernmentalapprovalsnecessaryforitsbusinessandoperations(the“LicensedPPPClinics”),totheNewWFOE.Totheumextentpermittedbytheapplicablelaws,anyfutureassets(includingmaterialinlectualproperties)oftheGroupshallbeownedintheNewWFOE’sname,andanyfuturebusinesscontractsshallbeenteredintobytheNewWFOE.TheNewWFOEshallbetheprimaryoperationalentityrelatedtothePrincipalStandardizationofBusinessCooperationwithLocalBusinessPartner.FollowingtheClosing,GroupCompaniesshallfurtherstandardizethebusinesscooperationwiththeirlocalbusinesspartners.SuchstandardizationshallbeinformandsubstancereasonablysatisfactorytotheInvestors,andshallincludebutnotlimitedto(i)securingprotectionforPPP’slogo,trademark,patent,know-howetc.;(ii)supervisingthebusinessoperation(products,proceduresandservicesintheconnectionwithlaser-lightcleaningservicesandprocedures)conductedbythelocalbusinesspartnersareinfullcompliancewiththepatternsetbytheGroupCompanies;and(iii)revisingandamendingrelatedlegal storeflectGroupCompanies’rightsandprivilegesasagreedamongthepartiestherein.EstablishmentoftheDomesticHoldingCompany.FollowingtheClosingandassoonaspracticable,theCompanyandtheFoundersshallcausetoestablishalimitedliabilitycompanyundertheapplicablePRClaw(the“DomesticHoldingEquityTransferoftheDomesticOperationCompanies.TheCompanyandtheFoundersshallfurthercausetheshareholdersoftheDirectOperationCompany,theFranchiseHoldingCompany,theProcurementCompany,andtheOldWFOE(collectivelythe“DomesticOperationCompanies”)totransferalltheequityintereststheyholdtotheDomesticHoldingCompanyforanominalconsiderationtotheumextentpermittedbytheapplicablelaws.TheprecedingequitytransfershallcausetheDomesticHoldingCompanytobesoleshareholderofalloftheoperationentitiesforthePrincipalBusiness.TransferofAssetsandBusinessContracts.IfthofdirectorsoftheCompanyconsidersfitanddesirablefortheCompany’sbusinessinterest,thematerialassets(includingmaterialinlectualproperties)andthebusinesscontractsoftheDomesticHoldingCompaniesandtheDomesticOperationCompaniesshall,totheumextentpermittedbytheapplicablelaws,betransferredtotheNewWFOE.Totheumextentpermittedbytheapplicablelaws,anyfuturethematerialassets(includingmaterialinlectualproperties)oftheGroupshallbeownedintheNewWFOE’snameandanyfuturebusinesscontractshallbeenteredintobytheNewWFOE.TransferofKeyEmployees.TheemploymentrelationshipofthemanagementemployeesandotherKeyEmployeesoftheDomesticHoldingCompanyandtheDomesticOperationCompaniesasrequestedbytheInvestorsshallbetransferredtotheNewWFOEfollowingtheClosingandassoonaspracticable.Totheumextentpermittedbyapplicablelaws,anyKeyEmployeeoftheGroupshallbeemployedbytheNewWFOE.NewClinicsOpening.Assoonaspracticable,butinanyeventnolaterthantwelve(12)monthsafterClosing,opentwenty(20)newPPPClinicsinthePRC.UseofProceeds.TheproceedsofthesaleofthePurchaseSharesshallbeusedforthebusinessdevelopmentandworkingcapitaloftheGroupinaccordancewiththebudgetandbusinessplanasapprovedbytheInvestors.Anti-Corruption.EachoftheGroupCompaniescovenantsthatitshallnot,andshallnotpermitanyofitssubsidiariesoraffiliatesoranyofitsortheirrespectivedirectors,officers,managers,employees,independentcontractors,representativesoragentsto,promise,authorizeormakeanypaymentto,orotherwisecontributeanyitemofvalueto,directlyorindirectly,anythirdparty,includinganynon-U.S.official,ineachcase,inviolationoftheForeignCorruptPracticesAct,theU.K.BriberyAct,oranyotherapplicableanti-briberyoranti-corruptionlawofanyotherjurisdiction.EachoftheGroupCompaniesfurthercovenantsthatitshall,andshallcauseeachofitssubsidiariesandaffiliatesto,ceaseallofitsortheirrespectiveactivities,aswellasremediateanyactionstakenbysuchGroupCompany,itssubsidiariesoraffiliates,oranyoftheirrespectivedirectors,officers,managers,employees,independentcontractors,representativesoragentsinviolationoftheForeignCorruptPracticesAct,theU.K.BriberyAct,oranyotherapplicableanti-briberyoranti-corruptionlawofanyotherjurisdiction.EachoftheGroupCompaniesfurthercovenantsthatitshall,andshallcauseeachofitssubsidiariesandaffiliatesto,maintainsystemsofinternalcontrols(including,butnotlimitedto,accountingsystems,purchasingsystemsandbillingsystems)toensurecompliancewiththeForeignCorruptPracticesAct,theU.K.BriberyAct,oranyotherapplicableanti-briberyoranti-corruptionlawofanyotherjurisdiction.IndemnityforHistoricalLiabilities.TheCovenantorsshalljointlyandseverallyindemnifytheInvestorsforanylosssufferedbysuchInvestorsasaresultof(i)anyGroupCompany’sfailuretoacquireallpermits,licensesorotherernmentalapprovalsnecessaryforanyGroupCompany’sPrincipalBusinessandoperationsforanytimeperiodpriortotheClosing;(ii)anyGroupanylitigation,arbitration,orinvestigationsthatarebroughtagainstanyGroupCompanypriortotheClosing.CompliancewithLaws.TheCovenantorsshallcausetheGroupCompaniestoconducttheirrespectivebusinessasnowconductedandasproposedtobeconductedincompliancewithallapplicablelawsonacontinuingbasis,includingbutnotlimitedtothelawsregardingforeigninvestments,corporateregistrationandfiling,importandexport,customsadministration,foreignexchange,advertisement, munication,financialservices,inlectualpropertyrights,taxation,laborandsocialwelfare,welfarefunds,socialbenefits,medicalbenefits,insurance,retirementbenefits,andpensionsorthelike.EachoftheGroupCompaniesshall,andeachoftheCovenantorsshallcausesuchGroupCompanyto,atalltimesmaintaintheappropriateernmentalpermitsorlicenseswhenandasrequiredbytheapplicablelawsorrelevanternmentauthoritytoconductitsrespectivebusiness.SatisfactionofConditions.TheCovenantorsshallusetheirrespectivebestefforttosatisfy(orcausethesatisfactionof)theClosingConditionsassoonasConsent.BetweentheSigningDateandtheClosingDate,theCovenantorsshallprocurethatnoindividualtransactionsinexcessofUS$100,000byanyGroupCompanyoranychangeintheequityinterestofanyGroupCompanyshalloccurwithouttheInvestors’priorwrittenconsent.FeesandExpenses.ThePartiesshallpayalloftheirowncostsandexpensesincurredinconnectionwiththenegotiation,execution,deliveryandperformanceofthisAgreementandotherTransactionsandthetransactionscontemplatedherebyandthereby;providedthattheCompanyshallbearthefeesandexpenseofthelegalcounselsselectedbyOCBCforthetransactionscontemplatedhereunderintheamountofUS$50,000,andtheCompanyshallreimbursesuchamounttoOCBCatClosing.Exclusivity.BetweentheSigningDateandtheClosingDate,theCovenantorsshallnot,andtheyshallnotpermitanyoftheirRepresentativesto,negotiateorengageinanytransactionsimilartothetransactionscontemplatedhereinorwithrespecttothesaleofalloranymaterialpartoftheassetsofanyGroupCompanywithanypartyotherthantheInvestors.EachCovenantorshallnotifytheInvestors(withinthree(3)BusinessDays)inquirymadebyathirdpartywithrespecttothesaleofanyorallofthePurchaseSharesoralloranymaterialpartoftheassetsofanyGroupCompanyand,ifsuchproposalorinquiryisinwriting,shalldelivertotheInvestorsacopyofsuchinquiryorproposal.ity.FromtheSigningDate,eachPartyshall,andshallcauseanywhoisControlledbysuchPartyto,keeptheexistenceandcontentofthisAgreement,theotherTransaction sandanyrelatedation,theidentitiesofanyoftheParties,andotherinformationofanon-publicnaturereceivedfromanyotherPartyorpreparedbysuchPartyexclusivelyinconnectionherewithortherewith(collectively,the“Information”)exceptastheCompanyandtheInvestorsshallmutuallyagreeotherwise;provided,thatanyPartyheretomaydiscloseInformationorpermitthedisclosureofInformation(a)totheextentrequiredbyapplicablelawsortherulesofanystockexchange;providedthatsuchPartyshall,wherepracticableandtotheextentpermittedbyapplicablelaws,providetheotherPartieswithpromptwrittennoticeofthatfactanduseallreasonableeffortstoseek(withthecooperationandreasonableeffortsoftheotherParties)aprotectiveorder,treatmentorotherappropriateremedy;andinsuchevent,suchPartyshallfurnishonlythatportionoftheinformationwhichislegallyrequiredtobedisclosedandshallexercisereasonableeffortstokeepsuchinformationtotheextentreasonablyrequestedbyanysuchotherParties,(b)toitsRepresentativesandprofessionaladvisorsonaneed-to-knowbasisfortheperformanceofitsobligationsinconnectionherewithsolongassuchPartyadvises towhomanyInformationissodisclosedastothenaturethereof,(c)inthecaseofeachoftheInvestors,toitsRepresentatives,auditors,counsel,shareholders,partnersorinvestors,and(d)toitscurrentorbonafideprospectiveinvestor,investmentbankersandanyotherwiseprovidingsubstantialdebtorequityfinancingtosuchPartysolongasthePartyadviseseach towhomanyInformationissodisclosedastothenaturethereof.Fortheavoidanceofdoubt,Informationdoesnotincludeinformationthat(i)wasalreadyinthepossessionofthereceivingPartybeforesuchdisclosurebythedisclosingParty,(ii)isor esavailabletothepublicotherthanasaresultofdisclosurebythereceivingPartyinviolationofthisSection6.9,or(iii)isor esavailabletothereceivingPartyfromathirdpartywhohasnoityobligationstothedisclosingParty.ThePartiesshallnotmakeanyannouncementregardingtheconsummationofthetransactioncontemplatedbythisAgreement,otherTransactionsandanyrelatedationinapressrelease,conference,advertisement,announcement,professionalortradepublication,marketingmaterialsorotherwisetothegeneralpublicwithouttheInvestors’priorwrittenconsent.UseofInvestors’NameorLogo.WithoutthepriorwrittenconsentoftheInvestors,andwhetherornottheInvestorsarethentheshareholdersoftheCompany,noneoftheGroupCompanies,theirshareholders(excludingtheInvestors),northeFoundersshalluse,publishorreproducethenamesoftheInvestorsoranysimilarnames,trademarksorlogosinanyoftheirmarketing,advertisingorpromotionmaterialsorotherwiseforanymarketing,advertisingorpromotionalpurposes.Permits.PriortotheClosingandassoonaspracticable,theDomesticOperationCompaniesshalluseallreasonableeffortstoacquireallpermits,licensesorotherernmentalapprovalsnecessaryforeachclinic’sbusinessandoperationssuchpermitsshallincludebutarenotlimitedtoPracticingLicenseofcosmetics.Eachofsuchpermitslicensesorotherernmentalapprovalsshallbevalidandinfullforceandeffect.AMPPL’sCertainRightsintheCompany.AMPPLandtheDirectOperationCompanyhaveenteredintoanInlectualPropertyAgreement(the“IPAgreement”)datedAugust1,2013,whichprovidesforbothparties’cooperationinconnectionwiththeestablishmentandexpansionofbusinessinlaser-lightfacialcleaningservicesandotherrelatedaestheticproductsandservicesinChina.TheIPAgreementhasgrantedAMPPLcertainrights,andallthepartieshereofhavemadefurtheragreementsasfollows:AMPPL’sAwarded10%SharesintheCompany.IntheeventthatthegrossturnoveroftheDomesticOperationCompaniesexceedsUSD30,000,000,RockStarAdvisorswilltransfer10%oftheCompany’soutstandingshares(onanas-convertedbasis)ownedbyRockStarAdvisorstoAMPPLforaminimumconsiderationpermittedbytheapplicablelaws,andsuchsharetransfershallnotresultinanydilutionorinfringementtoOCBC’sequityinterestintheCompany.AMPPL’sExercisingoftheCallOption.IntheeventthatthegrossturnoveroftheDomesticOperationCompaniesexceedsSingaporeDollar50,000,000,AMPPLmayexercisethecalloptiontopurchase51%s